BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21534873)

  • 1. Subdural hematomas in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving imatinib mesylate in conjunction with systemic and intrathecal chemotherapy.
    Patel SB; Gojo I; Tidwell ML; Sausville EA; Baer MR
    Leuk Lymphoma; 2011 Jul; 52(7):1211-4. PubMed ID: 21534873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal central nervous system prophylaxis in Philadelphia chromosome-positive acute lymphoblastic leukemia: collateral damage in the imatinib era?
    Bassan R
    Leuk Lymphoma; 2011 Jul; 52(7):1164-5. PubMed ID: 21612380
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
    Ottmann OG; Pfeifer H
    Hematology Am Soc Hematol Educ Program; 2009; ():371-81. PubMed ID: 20008223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Jeha S; Coustan-Smith E; Pei D; Sandlund JT; Rubnitz JE; Howard SC; Inaba H; Bhojwani D; Metzger ML; Cheng C; Choi JK; Jacobsen J; Shurtleff SA; Raimondi S; Ribeiro RC; Pui CH; Campana D
    Cancer; 2014 May; 120(10):1514-9. PubMed ID: 24501014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subdural hematomas during CML therapy with imatinib mesylate.
    Song KW; Rifkind J; Al-Beirouti B; Yee K; McCrae J; Messner HA; Keating A; Lipton JH
    Leuk Lymphoma; 2004 Aug; 45(8):1633-6. PubMed ID: 15370217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study.
    Schultz KR; Bowman WP; Aledo A; Slayton WB; Sather H; Devidas M; Wang C; Davies SM; Gaynon PS; Trigg M; Rutledge R; Burden L; Jorstad D; Carroll A; Heerema NA; Winick N; Borowitz MJ; Hunger SP; Carroll WL; Camitta B
    J Clin Oncol; 2009 Nov; 27(31):5175-81. PubMed ID: 19805687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study.
    Biondi A; Schrappe M; De Lorenzo P; Castor A; Lucchini G; Gandemer V; Pieters R; Stary J; Escherich G; Campbell M; Li CK; Vora A; Aricò M; Röttgers S; Saha V; Valsecchi MG
    Lancet Oncol; 2012 Sep; 13(9):936-45. PubMed ID: 22898679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term imatinib mesylate treatment.
    Riva G; Luppi M; Barozzi P; Quadrelli C; Basso S; Vallerini D; Zanetti E; Morselli M; Forghieri F; Maccaferri M; Volzone F; Del Giovane C; D'Amico R; Locatelli F; Torelli G; Comoli P; Potenza L
    Blood; 2010 Feb; 115(8):1512-8. PubMed ID: 20007806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).
    Wassmann B; Pfeifer H; Goekbuget N; Beelen DW; Beck J; Stelljes M; Bornhäuser M; Reichle A; Perz J; Haas R; Ganser A; Schmid M; Kanz L; Lenz G; Kaufmann M; Binckebanck A; Brück P; Reutzel R; Gschaidmeier H; Schwartz S; Hoelzer D; Ottmann OG
    Blood; 2006 Sep; 108(5):1469-77. PubMed ID: 16638934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment with imatinib mesylate in a case of minor BCR-ABL-positive acute myelogenous leukemia.
    Ito K; Tominaga K; Suzuki T; Jinnai I; Bessho M
    Int J Hematol; 2005 Apr; 81(3):242-5. PubMed ID: 15814335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment with imatinib combined with less intensive chemotherapy (vincristine and dexamethasone) as induction therapy in a very elderly patient with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Nishii K; Sakakura M; Tsukada T; Ryuu H; Katayama N
    Int J Hematol; 2007 Apr; 85(3):273-4. PubMed ID: 17483068
    [No Abstract]   [Full Text] [Related]  

  • 12. Prominent pleural effusion possibly due to imatinib mesylate in adult Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Ishii Y; Shoji N; Kimura Y; Ohyashiki K
    Intern Med; 2006; 45(5):339-40. PubMed ID: 16596010
    [No Abstract]   [Full Text] [Related]  

  • 13. A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias.
    Ottmann OG; Druker BJ; Sawyers CL; Goldman JM; Reiffers J; Silver RT; Tura S; Fischer T; Deininger MW; Schiffer CA; Baccarani M; Gratwohl A; Hochhaus A; Hoelzer D; Fernandes-Reese S; Gathmann I; Capdeville R; O'Brien SG
    Blood; 2002 Sep; 100(6):1965-71. PubMed ID: 12200353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imatinib: in relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukaemia.
    Cross SA; Lyseng-Williamson KA
    Drugs; 2007; 67(17):2645-54. PubMed ID: 18034597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of imatinib and cytarabine for the treatment of Philadelphia chromosome positive acute lymphoblastic leukemia.
    Morgensztern D; Rosado MF; Raez LE; Santos ES; Cassileth PA
    Leuk Lymphoma; 2005 Feb; 46(2):297-8. PubMed ID: 15621818
    [No Abstract]   [Full Text] [Related]  

  • 16. Childhood Philadelphia-chromosome-positive B-lymphoblastic leukaemia.
    Thomas D
    Lancet Oncol; 2012 Sep; 13(9):860-2. PubMed ID: 22935232
    [No Abstract]   [Full Text] [Related]  

  • 17. Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study.
    de Labarthe A; Rousselot P; Huguet-Rigal F; Delabesse E; Witz F; Maury S; Réa D; Cayuela JM; Vekemans MC; Reman O; Buzyn A; Pigneux A; Escoffre M; Chalandon Y; MacIntyre E; Lhéritier V; Vernant JP; Thomas X; Ifrah N; Dombret H;
    Blood; 2007 Feb; 109(4):1408-13. PubMed ID: 17062730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imatinib combined chemotherapy for Philadelphia chromosome-positive acute lymphoblastic leukemia: major challenges in current practice.
    Yanada M; Naoe T
    Leuk Lymphoma; 2006 Sep; 47(9):1747-53. PubMed ID: 17064984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow necrosis associated with the use of imatinib mesylate in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Matsue K; Takeuchi M; Koseki M; Uryu H
    Ann Hematol; 2006 Aug; 85(8):542-4. PubMed ID: 16570152
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and safety of imatinib mesylate (Glivec) in combination with interferon-alpha (IFN-alpha) in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL).
    Wassmann B; Scheuring U; Pfeifer H; Binckebanck A; Käbisch A; Lübbert M; Leimer L; Gschaidmeier H; Hoelzer D; Ottmann OG
    Leukemia; 2003 Oct; 17(10):1919-24. PubMed ID: 14513038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.